Cited by 29Vaccine Coverage and HesitancyHIV/AIDS Research and InterventionsCervical Cancer and HPV Research

HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach

Open access
Lee, Sung-Jae, Brooks, Ronald A., Newman, Peter A., Seiden, Danielle, Sangthong, Rassamee, Duan, Naihua·2008·AIDS Care

Abstract

This study examined HIV vaccine acceptability among immigrant Thai residents in Los Angeles, California. We combined a qualitative research method (focus groups) with an innovative market research method (conjoint analysis). Focus groups explored social issues, concerns, barriers and motivators associated with HIV vaccine acceptability. Conjoint analysis was used to assess preferences among eight hypothetical HIV vaccines with varying attribute profiles and the impact of various attributes on acceptability. Five main themes were identified in the focus groups regarding acceptance and utilization of preventive HIV vaccines: (1) vaccine characteristics, such as efficacy, physical side-effects and cost, (2) fear of a vaccine, (3) vaccine acceptability and optimism, (4) social and family responses and (5) behavioral disinhibition. Conjoint analysis revealed HIV vaccine acceptability ranging from 7.4 (SD = 19.4) to 85.2 (SD = 24.3) across eight hypothetical vaccines. The vaccine with the highest acceptability had the following attributes: 99% efficacy, no side-effects, 10 years of protection, protects against one sub-type, free, one dose and given by injection. Vaccine efficacy had the greatest impact on acceptability (51.4, p=.005), followed by side-effects (11.1, p=.005) and duration of protection (8.3, p=.005). Despite some apprehensions and concerns, Thai residents perceived an HIV vaccine as making an important contribution to society and to protecting oneself and one's family from HIV infection. Nevertheless, acceptability of a partially efficacious vaccine may be low, suggesting the need for tailored social marketing interventions that might emphasize a collectivistic rather than an individualistic focus. Assessing HIV vaccine acceptability using a mixed-method approach is feasible with Thai residents and should lend itself to HIV vaccine research with other Asian Pacific Islander populations in the US.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/09540120701855375

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. Allen MA Liang TS Salvia T Tjugum B Gulakowski RK Murgua M 2005 Assessing the attitudes, knowledge and awareness of HIV vaccine research among adults in the United States Journal of Acquired Immune Deficiency Syndromes 40 5 617 624 16284540
  2. Bogart LM Thornburn S 2005 Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? Journal of Acquired Immune Deficiency Syndromes 38 2 213 218 15671808
  3. Brooks RA Newman PA Duan N Ortiz DJ 2007 HIV vaccine trial preparedness among Spanish-speaking Latinos in the US AIDS Care 19 1 52 58 17129857
  4. Duan N 2005 Listening to consumers and HIV vaccine preparedness Lancet 365 9465 1119 1121 15794955
  5. Eckholdt H Chin J 1997 Pneumocystis carinii pneumonia in Asians and Pacific Islanders Clinical Infectious Diseases 24 265 1267 9195100
  6. Gilbert PB DeGruttola VG Hudgens MG Self SG Hammer SM Corey L 2003 What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: Issues involving surrogate end points in Phase 3 trials Journal of Infectious Diseases 188 2 179 193 12854072
  7. Green PE Wind J Rao VR Dorf RC 1999 Conjoint analysis: Methods and applications The technology management handbook 12/65 12/72 Boca Raton, FL CRC Press
  8. Horan PF DiClemente RJ 1993 HIV knowledge, communication and risk behaviors among white, Chinese- and Filipino-American adolescents in a high-prevalence AIDS epicenter: A comparative analysis Ethnicity and Disease 3 2 97 105 8324499
  9. Kellet N West F Finlay AY 2006 Conjoint analysis: A novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial British Journal of Dermatology 154 524 532 16445786
  10. Kittikorn N Street AF Blackford J 2006 Managing shame and stigma: Case studies of female carers of people with AIDS in southern Thailand Qualitative Health Research 16 9 1286 1301 17038758
  11. Levy JA 2001 What can be achieved with an HIV vaccine? Lancet 357 9251 223 224 11213112
  12. Newman PA Duan N Rudy ET Anton PA 2004a Challenges for HIV vaccine dissemination and clinical trial recruitment: If we build it, will they come? AIDS Patient Care and STDS 18 12 691 701 15659880
  13. Newman PA Duan N Rudy ET Johnston-Roberts K 2004b HIV risk and prevention in a post-vaccine context Vaccine 22 15–16 1954 1963 15121308
  14. Newman PA Duan N Rudy ET Roberts KJ Swendeman D 2004c Post-trial HIV vaccine adoption: Concerns, motivators, and intentions among persons at risk for HIV Journal of Acquired Immune Deficiency Syndromes 37 3 1393 1403 15483469
  15. Newman PA Duan N Roberts KJ Seiden D Rudy ET Swendeman D Popova S 2006a HIV vaccine trial participation among ethnic minority communities: Barriers, motivators, and implications for recruitment Journal of Acquired Immune Deficiency Syndromes 41 2 210 217 16394854
  16. Newman PA Duan N Lee SJ Rudy ET Seiden DS Kakinami L 2006b HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics Vaccine 24 12 2094 2101 16332402 PMC2819665
  17. Phillips KA Johnson FR Maddala T 2002 Measuring what people value: A comparison of “attitude” and “preference” surveys Health Services Research 37 1659 1679 12546291 PMC1464045
  18. Roberts KJ Newman PA Duan N Rudy ET Swendeman D 2005 HIV vaccine knowledge and beliefs among communities at elevated risk: Concerns, questions and conspiracies Journal of the National Medical Association 97 12 1662 1671 16396058 PMC2640722
  19. Ryan M McIntosh E Shackley P 1998 Methodological issues in the application of conjoint analysis in healthcare Health Economics 7 4 373 378 9683097
  20. Sengupta S Strauss RP DeVellis R Quinn SC DeVellis B Ware W 2000 Factors affecting African-American participation in AIDS research Journal of Acquired Immune Deficiency Syndromes 24 3 275 284 10969353
  21. Strauss RP Sengupta S Kegeles S McLellan E Metzger D Eyre S 2001 Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three US communities Journal of Acquired Immune Deficiency Syndromes 26 63 71 11176270
  22. Suraratdecha C Ainsworth M Tangcharoensathien V Whittington D 2005 The private demand for an AIDS vaccine in Thailand Health Policy 71 271 287 15694496
  23. Sy FS Chng CL Choi ST Wong FY 1998 Epidemiology of HIV and AIDS among Asian/Pacific Islanders AIDS Education and Prevention 10 Suppl A 4 18 9642427
  24. Tangcharoensathien V Phoolcharoen W Pitayarangsarit S Kongsin S Kasemsup V Tantivess S 2001 The potential demand for an AIDS vaccine in Thailand Health Policy 57 2 111 139 11395178
  25. VanLandingham MJ Im-Em W Saengtienchai C 2005 Community reaction to persons with HIV/AIDS and their parents: An analysis of recent evidence from Thailand Journal of Health and Social Behavior 46 4 392 410 16433283
  26. Wortley PM Metler RP Hu DJ Fleming PL 2000 AIDS among Asians and Pacific Islanders in the United States American Journal of Preventive Medicine 18 3 208 214 10722986

Cited by

Sorted by citations

Authors
Lee, S.-J., Brooks, R. A., Newman, P. A., Seiden, D., Sangthong, R., & Duan, N.
Affiliations
  • University of California, Los Angeles (US)
  • University of Toronto (CA)
  • Prince of Songkla University (TH)
  • New York State Psychiatric Institute (US)
Corresponding author
Lee, Sung-Jae
Venue
AIDS Care
Published
2008-11
Volume
20
Issue
10
Pages
1161-1168
ISSN
  • 0954-0121 (ISSN-L)
  • 1360-0451
OpenAlex
W1988827122
Cited by
29
References
1
Citations by year
2026: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2014: 3 · 2013: 4 · 2012: 2
FWCI
2.48
Type
journal article
Language
en
Open access
Locations
  • AIDS Care (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institute of Mental Health (P30 MH-58107, P30MH058107)
  • Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles (P30MH58107)
Topics
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
Los Angeles, vaccine efficacy, vaccine side effects, duration of protection, vaccine cost, behavioral disinhibition, social marketing, collectivist values, vaccine preferences
MeSH terms
Adult, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Thailand, Los Angeles, HIV Infections, AIDS Vaccines, Focus Groups, Emigrants and Immigrants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review